Martin aka paused||M.E.
Senior Member
- Messages
- 2,291
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
I think it’s more du to its properties regarding the serotonin receptors... haven’t seen any other drug with exact the same effects... that would perhaps implement in the metabolic trap theory... at least better than dopamine agonism ...I dont think the main benefit of Abilify is through its Dopamine modulation. I took Quetiapine with a VERY similar mechanic for several yeras without effect.
Abilify seems to be unique in reducing cytokine induced inflammation in the brain.
With a leaky brain barrier we get all kinds of unwated immune reactions to our brain.
I dont think the main benefit of Abilify is through its Dopamine modulation. I took Quetiapine with a VERY similar mechanic for several yeras without effect.
Abilify seems to be unique in reducing cytokine induced inflammation in the brain.
With a leaky brain barrier we get all kinds of unwated immune reactions to our brain.
Also an agonist for 5-HT2a receptors. No control group in the study @Martin aka paused||M.E. so there is a possibility of placebo effect. Needs to be a proper double blind trial. I would expect the results of any such trial would rule out placebo effect. But then I'm an optimist!
Is there any chance there is a similar mast cell stabilising property to abilify.Yes Benzos stabilize mast cells!